Latest Cervical intraepithelial neoplasia Stories
Large-scale study shows potential for non-invasive test to be made available to millions of women worldwide who are unscreened for the detection of cervical cancer SAN DIEGO, Feb.
Dr. Gelder's Accomplishments Include Successful Development of Cancer Therapies at Pfizer, Wyeth and Bayer PLYMOUTH MEETING, Pa., Jan.
TAMPA, Fla., Jan.
SGO, ASCCP leverage newly published end-of-study data to support option of HPV primary screening for women 25 and older INDIANAPOLIS, Jan.
Company Expands IP Portfolio Covering Test Methods to Identify Chromosomal Abnormalities including 3q (TERC) and 5p (TERT) in Cervical Cells GAITHERSBURG, Md., Oct.
SEATTLE, Aug. 25, 2014 /PRNewswire/ -- Trovagene, Inc.
A study published online in the International Journal of Cancer earlier this month describes a novel approach to preventing cervical cancer based on findings showing successful reduction in the risk of cervical cancer after removal of a discrete population of cells in the cervix.
Treatment with VGX-3100 induces regression of precancerous cervical disease and clears HPV infection with robust T cell responses PLYMOUTH MEETING, Pa., July 23, 2014 /PRNewswire/
LAVAL, QC, June 10, 2014 /CNW Telbec/ - Roche announced that Health Canada approved the cobas® 4800 HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical
NORTH BRUNSWICK, N.J., Feb.
- Large; stout; burly.